Tag
What would it take to control drug prices?
Drug price inflation soars even as prices in the wider economy are stable.
The European Union has some 20 "biosimilar" generics on the market; the US has one.
Hedge funds are joining groups who want to lower prescription prices for consumers.
The company's CEO stepped down on Monday
A new report suggests drug makers are profiting from the waste.
Its Caremark unit covers some 25 million U.S. customers
The industry worries it's a step toward price controls.
More generics are needed to create competition — but can the FDA approve them fast enough?
It's not just a few bad players, as Congressional hearing puts drug costs in focus.
